What is Gambhari?
Gambhari, scientifically known as Gmelina arborea, is a fast-growing deciduous tree belonging to the Lamiaceae family. Native to India and Southeast Asia, it is commonly found in a variety of habitats, including forests, plains, and riverbanks. The tree is characterized by its yellowish-brown bark, heart-shaped leaves, and clusters of yellow flowers that give way to yellowish, juicy fruits.
Valued for its timber, which is lightweight yet durable, Gambhari also holds traditional significance. Various parts of the tree, including its root, bark, and fruit, have been utilized across different cultures for their purported properties.
Other Names of Gambhari
- Beechwood
- Gmelina
- Gumhar
- Kumbhi
Heading
<h3> Absolute Contraindications of Gambhari </h3> <p>Summary: There are no well-documented human clinical trials that identify formal, universal “absolute” contraindications for Gambhari. Repeated-dose and acute toxicity studies in rodents found no mortality or major organ toxicity at high doses, suggesting a favorable preclinical safety profile. However, because human data are limited, clinical prudence leads to a short list of situations where use is advised against or avoided until a clinician approves (rationale and supporting preclinical studies are cited below).</p> <h4> Pregnancy & Breastfeeding (lack of human safety data)</h4> <ul> <li>🤰</li> <li>Recommendation: Avoid Gambhari during pregnancy and breastfeeding unless an experienced clinician advises otherwise.</li> <li>Reasoning: There are no adequate human reproductive safety studies; animal toxicology focused on general acute/repeated toxicity but did not provide reproductive-development safety data, so prudence demands avoidance in pregnancy/lactation.</li> <li>Scientific_Study_Title: Toxicological Evaluation of the Methanol Extract of Gmelina arborea Roxb. Bark in Mice and Rats</li> <li>Scientific_Study_Authors: Y A Kulkarni, A Veeranjaneyulu</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22778509/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: The study tested methanolic stem-bark extract across acute (300-5000 mg/kg) and 28-day repeated-dose regimens (300-2000 mg/kg/day) in mice and rats and found no mortality or major clinical, biochemical, hematological, or histopathological changes at tested doses. The authors report a high NOAEL under the conditions studied, but the work did not include focused reproductive-development (teratology/embryofetal) assessments; therefore, specific safety for pregnancy or lactation cannot be inferred from this dataset.</p> <p>This absence of reproductive data is why pregnancy/lactation remain contraindicated until dedicated studies or clinical evidence demonstrate safety.</p> </li> </ul> <h4>Severe Hypotension or Uncontrolled Low Blood Pressure</h4> <ul> <li>🩺</li> <li>Recommendation: Do not use Gambhari if you have symptomatic low blood pressure or are hemodynamically unstable; consult a clinician first.</li> <li>Reasoning: Preclinical studies report endothelium-dependent vasorelaxation and blood-pressure-modulating effects; in people with already low pressure, further vasodilation could worsen hypotension.</li> <li>Scientific_Study_Title: In vivo antioxidant and vasodilating activities of Gmelina arborea (Verberaceae) leaves hexane extract</li> <li>Scientific_Study_Authors: Sylvie L Wansi, Paulin Nyadjeu, Télesphore Benoît Nguelefack, Siaka F K Fodouop, Atsamo Albert Donatien, Albert Kamanyi</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23045387/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In this animal study, G. arborea hexane leaf extract elevated tissue antioxidant markers and produced concentration-dependent vasorelaxation of isolated rat aortic rings; vasodilatory responses were reduced after endothelium removal or pretreatment with L-NAME or indomethacin, implicating endothelial NO and related pathways. The extract also prevented vascular remodeling in a high-salt model. These pharmacodynamic effects support a plausible risk of additive hypotension when combined with other vasodilators or in patients with low baseline blood pressure.</p> </li> </ul> <h4>Concurrent use with Strong Hypoglycemic Therapy (insulin, sulfonylureas) - caution</h4> <ul> <li>🩸</li> <li>Recommendation: People on insulin or potent oral hypoglycemics should avoid unsupervised use of Gambhari or should consult their physician and monitor blood glucose closely if use is considered.</li> <li>Reasoning: Gambhari extract lowered blood glucose in diabetic rodent models; combined use with glucose-lowering drugs could lead to additive hypoglycemia.</li> <li>Scientific_Study_Title: Effects of Gmelina arborea extract on experimentally induced diabetes</li> <li>Scientific_Study_Authors: Yogesh Anant Kulkarni, Addepalli Veeranjaneyulu</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23790330/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In streptozotocin-induced diabetic rats, aqueous bark extract of G. arborea produced significant reductions in plasma glucose after single and 28-day dosing and improved diabetic markers (reduced polyphagia/polydipsia and body weight loss). The extract did not lower glucose in normal rats, but its clear antihyperglycemic effect in diabetic models suggests additive glucose-lowering potential if combined with prescribed hypoglycemic medications.</p> </li> </ul> <h3> Relative Contraindications of Gambhari </h3> <p>These are situations where Gambhari may be used with caution, dose adjustment, or clinical supervision. The items below are based on plausible pharmacology and the available preclinical literature.</p> <h4>Use with Antihypertensive Drugs (ACE inhibitors, nitrates, calcium-channel blockers)</h4> <ul> <li>⚖️</li> <li>Recommendation: Use only under medical supervision; monitor blood pressure regularly and adjust antihypertensive dosing if necessary.</li> <li>Reasoning: Vasorelaxant and antioxidant effects can potentiate blood-pressure lowering drugs, producing symptomatic hypotension in sensitive patients.</li> <li>Scientific_Study_Title: In vivo antioxidant and vasodilating activities of Gmelina arborea (Verberaceae) leaves hexane extract</li> <li>Scientific_Study_Authors: Sylvie L Wansi, Paulin Nyadjeu, Télesphore Benoît Nguelefack, Siaka F K Fodouop, Atsamo Albert Donatien, Albert Kamanyi</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23045387/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: The leaf hexane extract produced concentration-dependent endothelium-dependent relaxation and increased NO and antioxidant enzyme levels in treated animals; vasodilatory effects were attenuated by endothelial removal or NOS inhibition, indicating that the herb acts on pathways also targeted by several antihypertensive drugs. Therefore co-administration could lead to enhanced blood-pressure lowering.</p> </li> </ul> <h4>Concurrent Use with Chemotherapy - requires oncologist input (possible interaction)</h4> <ul> <li>💊</li> <li>Recommendation: Inform your oncologist before using Gambhari; do not self-administer during chemotherapy without specialist approval.</li> <li>Reasoning: In animal models Gambhari stem-bark extract showed nephroprotective effects against adriamycin (doxorubicin) toxicity - this may be beneficial, but interactions with chemotherapy pharmacokinetics or therapeutic effect are not fully studied in humans.</li> <li>Scientific_Study_Title: Standardized aqueous stem bark extract of Gmelina arborea roxb. possesses nephroprotection against adriamycin-induced nephrotoxicity in Wistar rats</li> <li>Scientific_Study_Authors: Sachinthi S Amarasiri, Anoja P Attanayake, Liyanagae D A M Arawwawala, Kamani A P W Jayatilaka, Lakmini K B Mudduwa</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32865030/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In an adriamycin-induced nephrotoxicity rat model, standardized aqueous G. arborea bark extract administered orally reduced serum markers of renal injury (creatinine, BUN, cystatin C, β2-microglobulin) and improved histologic renal damage in a dose-dependent manner. While this suggests nephroprotection, the study does not evaluate effects on chemotherapy efficacy or systemic drug levels in humans - thus clinical guidance is required before combining with chemotherapeutic regimens.</p> </li> </ul> <h4>Known Allergy to Gmelina-family Components</h4> <ul> <li>⚠️</li> <li>Recommendation: Do not use if you have a known allergy to Gambhari or related plant constituents; seek alternative therapies.</li> <li>Reasoning: As with any botanical product, idiosyncratic allergic reactions are possible though not well documented in clinical literature; absence of reports is not proof of absence of risk.</li> <li>Scientific_Study_Title: (No human allergy case-series located in PubMed; precaution based on general allergenic risk of botanicals)</li> <li>Scientific_Study_Authors: NA</li> <li>Scientific_Study_Link: NA</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: PubMed searches did not retrieve formal human case reports of hypersensitivity specific to Gmelina arborea. Because plant extracts contain diverse proteins and small molecules, hypersensitivity remains a theoretical risk; therefore avoidance in known allergic individuals is standard prudent practice.</p> </li> </ul>
Heading
<h4>Stomach upset / gastrointestinal discomfort</h4> <ul> <li>🤢</li> <li>Side effect summary: Some traditional sources report stomach troubles (nausea, mild gastritis) when Gambhari is used in excess or without proper formulation/dose.</li> <li>Recommendation: Start with small, practitioner-recommended doses; stop if you get persistent stomach pain or severe digestive symptoms and consult a clinician.</li> <li>Reasoning: Although animal studies show gastroprotective effects in controlled models, raw or high-dose preparations can irritate sensitive stomachs in some individuals (traditional reports); human safety trials are lacking.</li> <li>Severity Level: Mild</li> <li>Scientific_Study_Available: NA</li> <li>Scientific_Study_Title: NA</li> <li>Scientific_Study_Authors: NA</li> <li>Scientific_Study_Link: NA</li> <li>Scientific_Study_Excerpt: NA</li> </ul> <h4>Idiosyncratic allergic reaction (rare/unreported formally)</h4> <ul> <li>🫧</li> <li>Side effect summary: Possible but not described in controlled human studies-could include rash, itching or respiratory symptoms in hypersensitive people.</li> <li>Recommendation: Discontinue immediately and seek medical care if signs of allergy occur.</li> <li>Reasoning: Lack of published human case reports does not eliminate the possibility; botanical products can cause hypersensitivity in susceptible people.</li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: NA</li> <li>Scientific_Study_Title: NA</li> <li>Scientific_Study_Authors: NA</li> <li>Scientific_Study_Link: NA</li> <li>Scientific_Study_Excerpt: NA</li> </ul> <h4>Potential for additive blood-pressure lowering or glucose-lowering when combined with drugs</h4> <ul> <li>📉</li> <li>Side effect summary: When combined with antihypertensives or hypoglycemic medications, Gambhari may increase the effect of those drugs and cause symptomatic hypotension or hypoglycemia.</li> <li>Recommendation: If you take blood-pressure or diabetes medications, discuss Gambhari use with your prescribing clinician and monitor vital signs/glucose closely.</li> <li>Reasoning: Preclinical vasorelaxant and antihyperglycemic effects support potential for additive pharmacologic activity when combined with related drug classes. </li> <li>Severity Level: Moderate</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Title: In vivo antioxidant and vasodilating activities of Gmelina arborea (Verberaceae) leaves hexane extract; Effects of Gmelina arborea extract on experimentally induced diabetes</li> <li>Scientific_Study_Authors: Sylvie L Wansi et al.; Yogesh Anant Kulkarni, Addepalli Veeranjaneyulu</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23045387/ ; https://pubmed.ncbi.nlm.nih.gov/23790330/</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: Vasorelaxation studies demonstrate endothelium-dependent relaxation and antioxidative vascular effects, while diabetic rat models show significant antihyperglycemic action in diabetic animals. Together these findings indicate possible additive effects with antihypertensive and antidiabetic medications, meriting clinical caution and monitoring when co-administered.</p> </li> </ul>
Heading
<h4>Antihypertensive drugs (ACE inhibitors, ARBs, nitrates, calcium-channel blockers)</h4> <ul> <li>Interaction_Details: Gambhari extracts produce endothelium-dependent vasorelaxation and increase NO/antioxidant signaling in animal models; combining with antihypertensive drugs could amplify blood-pressure lowering and cause symptomatic hypotension.</li> <li>Severity: Moderate</li> <li>Recommendation: Monitor blood pressure closely and use under medical supervision; dose adjustments of antihypertensives may be necessary.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23045387/</li> <li>Scientific_Study_Title: In vivo antioxidant and vasodilating activities of Gmelina arborea (Verberaceae) leaves hexane extract</li> <li>Scientfic_Study_Authors: Sylvie L Wansi, Paulin Nyadjeu, Télesphore Benoît Nguelefack, Siaka F K Fodouop, Atsamo Albert Donatien, Albert Kamanyi</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: The study reported that G. arborea hexane leaf extract enhanced antioxidant enzyme activities and produced concentration-dependent vasorelaxation of isolated rat aorta; vasodilation was reduced after mechanical denudation of the endothelium or by NOS and prostaglandin pathway inhibitors. These findings indicate engagement with endothelial NO and prostaglandin pathways that are also targeted by common antihypertensive agents, offering a mechanistic basis for additive blood-pressure lowering effects when co-administered.</p> </li> </ul> <h4>Antidiabetic medications (insulin, sulfonylureas, meglitinides)</h4> <ul> <li>Interaction_Details: Aqueous Gambhari extracts lowered blood glucose in diabetic animal models; co-use with prescription hypoglycemics could produce additive glucose reduction and hypoglycemia.</li> <li>Severity: Moderate</li> <li>Recommendation: Frequent glucose monitoring is advised; consult the prescribing clinician before starting Gambhari to consider dose adjustments of antidiabetic drugs.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23790330/</li> <li>Scientific_Study_Title: Effects of Gmelina arborea extract on experimentally induced diabetes</li> <li>Scientfic_Study_Authors: Yogesh Anant Kulkarni, Addepalli Veeranjaneyulu</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In streptozotocin-induced diabetic rats, oral aqueous bark extract significantly reduced plasma glucose in both acute and subacute studies and improved diabetic symptoms; it did not lower glucose in normoglycemic rats. The clear antihyperglycemic effect in experimental diabetes models supports a real potential for additive hypoglycemic interactions with glucose-lowering drugs.</p> </li> </ul> <h4>Doxorubicin (Adriamycin) / Certain Chemotherapeutic Agents</h4> <ul> <li>Interaction_Details: Preclinical data show Gambhari bark extract can reduce doxorubicin-induced nephrotoxicity in rats; this indicates a potentially protective interaction but also means close coordination with oncology care is needed before co-use.</li> <li>Severity: Mild</li> <li>Recommendation: Discuss with the oncology team; do not self-administer during chemotherapy without specialist approval.</li> <li>Scientific_Study_Available: Yes</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/32865030/</li> <li>Scientific_Study_Title: Standardized aqueous stem bark extract of Gmelina arborea roxb. possesses nephroprotection against adriamycin-induced nephrotoxicity in Wistar rats</li> <li>Scientfic_Study_Authors: Sachinthi S Amarasiri, Anoja P Attanayake, Liyanagae D A M Arawwawala, Kamani A P W Jayatilaka, Lakmini K B Mudduwa</li> <li>Scientific_Study_Excerpt: <p>Paraphrase: In an adriamycin nephrotoxicity model, standardized aqueous G. arborea bark extract lowered serum creatinine, BUN and other renal injury markers and attenuated histologic kidney damage in a dose-dependent way. The authors concluded the extract exerted nephroprotection likely via antioxidant mechanisms; however, the impact on chemotherapy pharmacodynamics or antitumor efficacy was not assessed in this study, hence clinical coordination is required.</p> </li> </ul>
